Cargando…
Corrigendum to “Hematological Inflammatory Markers in Patients with Clinically Confirmed Familial Hypercholesterolemia”
Autores principales: | Vaseghi, Golnaz, Heshmat-Ghahdarijani, Kiyan, Taheri, Marzieh, Ghasempoor, Ghazal, Hajian, Shabnam, Haghjooy-Javanmard, Shaghayegh, Aliyari, Roqayeh, Shafiee, Zahra, Shekarchizadeh, Masoud, Pourmoghadas, Ali, Sarrafzadegan, Nizal |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10098407/ https://www.ncbi.nlm.nih.gov/pubmed/37065721 http://dx.doi.org/10.1155/2023/9851784 |
Ejemplares similares
-
Hematological Inflammatory Markers in Patients with Clinically Confirmed Familial Hypercholesterolemia
por: Vaseghi, Golnaz, et al.
Publicado: (2022) -
Angiotensin-converting-enzyme inhibitors (ACE inhibitors) and angiotensin II receptor blocker (ARB) use in COVID-19 prevention or treatment: A paradox
por: Javanmard, Shaghayegh Haghjooy, et al.
Publicado: (2020) -
Familial Hypercholesterolemia (FH) in Iran: Findings from the Four-Year FH Registry
por: Vaseghi, Golnaz, et al.
Publicado: (2021) -
Co-infection between the severe acute respiratory syndrome coronavirus 2 and the influenza Type B in Isfahan, Iran
por: Heshmat-Ghahdarijani, Kiyan, et al.
Publicado: (2021) -
Vitamin D Level in Laboratory Confirmed COVID-19 and Disease Progression
por: Dana, Nasim, et al.
Publicado: (2022)